PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
12.78%
Net income growth similar to BB's 13.01%. Walter Schloss would find parallel expansions or market conditions in both firms’ profitability.
3.46%
Less D&A growth vs. BB's 9.21%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-100.41%
Negative yoy deferred tax while BB stands at 124.08%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
0.21%
Less SBC growth vs. BB's 2.53%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
850.02%
Slight usage while BB is negative at -185.55%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-312.84%
AR is negative yoy while BB is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3376.90%
Growth of 3376.90% while BB is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-6730.77%
Negative yoy while BB is 117.24%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-24.20%
Both yoy CFO lines are negative, with BB at -27.75%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-85.78%
Negative yoy CapEx while BB is 13.33%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
271.33%
Some acquisitions while BB is negative at -108.27%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
62.79%
Purchases well above BB's 0.97%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-60.52%
Both yoy lines are negative, with BB at -77.29%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
No Data
No Data available this quarter, please select a different quarter.
30.23%
We have mild expansions while BB is negative at -994.77%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
24.56%
Debt repayment growth of 24.56% while BB is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-436.97%
Both yoy lines negative, with BB at -5.28%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-89.77%
We cut yoy buybacks while BB is 99.31%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.